Scicoins

Scicoins

PRE-SALE ENDED
12,894 Views
SciX LLC is currently releasing an ICO initiative to establish a decentralized, permission-based platform which will house our smart contracts that securely monitor and aggregate collective data from IoT wearables used in medical science. We recently were selected by the NIH in an effort to secure government contracts with the industry and deploy blockchain-technology solutions for multiple medical practices. Our team of medical and technological professionals have combined forces to solidify these projects.
3.9
TOTAL SCORE
3.5
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
Pre-sale Time: 18 Feb 2018 - 28 Feb 2018
Country: USA
Token info
Ticker: SCI
Platform: Ethereum
Token Type: ERC20
Financial
ICO Price: 1 SCI = 0.001 ETH
Soft cap: 10000000 SCI
Hard cap: 400000000 SCI
Social media
Screenshots taken on 22 Feb 2018
Gloryvee Cordero
CTO & Co-Founder
Participates in a number of projects
Joyonna Gamble-George
Founder
Participates in a number of projects
Timothy Boyd
Sciencist
Participates in a number of projects
Rodrick Colbert
Business Development
Participates in a number of projects
Judi Ebbert
Clinical Science Writer And Editor
Participates in a number of projects
Karon L. Phillips
Public Health Gerontologist, Health Education And Aging-in-place Specialist
Participates in a number of projects
Mikael Vinding
Blockchain Engineer
Participates in a number of projects
Decontee Jimmeh
Neurologist
No participating data
Genica Proctor-Sutton
Community And State Clinical Pharmacist
Participates in a number of projects
Neil Gomes
CDO
Participates in a number of projects
Mary Fleming
Obstetrician
Participates in a number of projects
Aprill Dawson
Program Manager
Participates in a number of projects
Muoyo Okome
Participates in a number of projects
Bruno Silas
CRO
Participates in a number of projects
Godspower Esogban
General Practitioner, Public Health Advocate
Participates in a number of projects
Sohee Jeon
Ophthalmologist
Participates in a number of projects
Peter Asilia
General Practitioner, Clinical Research Coordinator
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Beyond Seen Screen
Beyond Seen Screen has created a platform that enables interactivity with video content. With Beyond Seen Screen watching video content is no longer a passive action, a one-way street. The platform enables content producers and content distribution companies to link additional information to the video content. Viewers will no longer only passively receive adverts, trailers and other video content but will have ability to interactively engage with them by using their mobile device.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Upcoming
Data Choice
Take control of your personal data. Your data is used virtually every second you are online, to target you with ads. Data Choice will allow you to take control of what you share, what you keep private, control of the ads you see, and reward you for your data being used.
Upcoming
Potentiam
The founders of Potentiam have worked in music management for a number of years and realise and understand the difficulties involved in promoting new emerging music artists. In 2016 they founded a music publication Britznbeatz to help discover and promote musicians which continues to gain respect and recognition in the industry.
Upcoming
Ispolink
Ispolink is cutting-edge automated matchmaking job board platform that leverages Blockchain and Artificial Intelligence (AI) technology to address one of the most fundamental challenges that exist nowadays – sourcing and attracting qualified personnel. We strive to empower companies operating in the blockchain and IT domain to fill their positions by providing them a full spectrum of tools to conduct and manage in-house the entire recruitment process efficiently - ranging from candidate sourcing, screening, through the various stages of interviews until the final offer, eliminating the need of intermediaries such as HR agencies. As per the job seekers, the platform is tailored to improve their overall experience by reducing the prolonged job searching, the endless waiting for feedback, coupled with convenience to receive the best offers with only a few clicks. Ispolink’s blockchain based product facilitates the processes for filling roles by providing a full cycle recruitment system. The platform will make the entire recruitment process more transparent, optimized, automated and also to help organizations to enhance their internal communication which will result in substantial cost and time reductions